NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders
Sara Mariotto, Matteo Gastaldi, Luisa Grazian, Chiara Mancinelli, Ruggero Capra, Romain Marignier, Daniela Alberti, Serena Zanzoni, Kathrin Schanda, Diego Franciotta, Francesca Calabria, Salvatore Monaco, Markus Reindl, Sérgio Ferrari, Alberto Gajofatto
Topics & Concepts
MedicineMultiple sclerosisDiseaseMyelin oligodendrocyte glycoproteinAge of onsetInternal medicineOligodendrocyteGastroenterologyMyelinImmunologyPathologyCentral nervous systemExperimental autoimmune encephalomyelitisMultiple Sclerosis Research StudiesNeurogenetic and Muscular Disorders ResearchPolyomavirus and related diseases